Homology Medicines
(NASDAQ) FIXX
This security has been delisted. This page is retained for historical reference.
FIXX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowFIXX Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
31%
Net Income Margin
55%
Return on Equity
16%
Return on Capital
34%
Return on Assets
48%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$16.90M
EBITDA
$16.90M
Operating Cash Flow
$33.54M
Capital Expenditure
$2.00K
Free Cash Flow
$33.54M
Cash & ST Invst.
$48.30M
Total Debt
$11.18M
Homology Medicines Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
+100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
7
N/A
Net Income
$57.73M
+2818.6%
EBITDA
$45.88M
+366.2%
Quarterly Fundamentals
Net Cash
$37.12M
-46.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$4.94M
-12.3%
Short Term Debt
$6.24M
+101.3%
Return on Assets
48.27%
N/A
Return on Invested Capital
33.52%
N/A
Free Cash Flow
$0.00
+100.0%
Operating Cash Flow
$0.00
+100.0%